154 related articles for article (PubMed ID: 35842313)
1. Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology.
Pirtea P; de Ziegler D; Marin D; Sun L; Tao X; Ayoubi JM; Franasiak J; Scott RT
Fertil Steril; 2022 Sep; 118(3):494-503. PubMed ID: 35842313
[TBL] [Abstract][Full Text] [Related]
2. Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization.
Lindgren I; Bååth M; Uvebrant K; Dejmek A; Kjaer L; Henic E; Bungum M; Bungum L; Cilio C; Leijonhufvud I; Skouby S; Andersen CY; Giwercman YL
Hum Reprod; 2016 Mar; 31(3):672-83. PubMed ID: 26769719
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin receptor variants are linked to cumulative live birth rate after in vitro fertilization.
Lindgren I; Nenonen H; Henic E; Bungum L; Prahl A; Bungum M; Leijonhufvud I; Huhtaniemi I; Yding Andersen C; Lundberg Giwercman Y
J Assist Reprod Genet; 2019 Jan; 36(1):29-38. PubMed ID: 30232643
[TBL] [Abstract][Full Text] [Related]
4. Luteinizing Hormone/Human Chorionic Gonadotropin Receptor N312S Single-Nucleotide Polymorphism and Its Impact on Clinical and Reproductive Outcomes in Assisted Reproductive Technology: A Prospective Cohort Study.
Nagulapalli A; Vembu R; Pandurangi M; Nellepalli SR
Cureus; 2023 Oct; 15(10):e47217. PubMed ID: 38022167
[TBL] [Abstract][Full Text] [Related]
5. Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study.
Simoni M; Santi D; Negri L; Hoffmann I; Muratori M; Baldi E; Cambi M; Marcou M; Greither T; Baraldi E; Tagliavini S; Carra D; Lombardo F; Gandini L; Pallotti F; Krausz C; Rastrelli G; Ferlin A; Menegazzo M; Pignatti E; Linari F; Marino M; Benaglia R; Levi-Setti PE; Behre HM
Hum Reprod; 2016 Sep; 31(9):1960-9. PubMed ID: 27329968
[TBL] [Abstract][Full Text] [Related]
6. The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation.
Nenonen HA; Lindgren IA; Prahl AS; Trzybulska D; Kharraziha I; Hultén M; Giwercman YL; Henic E
Pharmacogenet Genomics; 2019 Jul; 29(5):114-120. PubMed ID: 30829738
[TBL] [Abstract][Full Text] [Related]
7. Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome.
Almawi WY; Hubail B; Arekat DZ; Al-Farsi SM; Al-Kindi SK; Arekat MR; Mahmood N; Madan S
J Assist Reprod Genet; 2015 Apr; 32(4):607-14. PubMed ID: 25649397
[TBL] [Abstract][Full Text] [Related]
8. Role of Lh polymorphisms and r-hLh supplementation in GnRh agonist treated ART cycles: A cross sectional study.
G A R; Cheemakurthi R; Prathigudupu K; Balabomma KL; Kalagara M; Thota S; Kota M
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():119-125. PubMed ID: 29408742
[TBL] [Abstract][Full Text] [Related]
9. Associations of FSHR and LHCGR gene variants with ovarian reserve and clinical pregnancy rates.
Guo C; Yu H; Feng G; Lv Q; Liu X; Liu X
Reprod Biomed Online; 2021 Sep; 43(3):561-569. PubMed ID: 34391684
[TBL] [Abstract][Full Text] [Related]
10. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
11. Post-trigger luteinizing hormone concentration to positively predict oocyte yield in the antagonist protocol and its association with genetic variants of LHCGR.
Jin H; Yang H; Zheng J; Zhou J; Yu R
J Ovarian Res; 2023 Sep; 16(1):189. PubMed ID: 37691102
[TBL] [Abstract][Full Text] [Related]
12. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype.
Lledó B; Dapena P; Ortiz JA; Morales R; Llacer J; Bernabeu R
Pharmacogenet Genomics; 2016 Jun; 26(6):288-93. PubMed ID: 26959715
[TBL] [Abstract][Full Text] [Related]
14. The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia.
Polyzos NP; Neves AR; Drakopoulos P; Spits C; Alvaro Mercadal B; Garcia S; Ma PQM; Le LH; Ho MT; Mertens J; Stoop D; Tournaye H; Vuong NL
Hum Reprod; 2021 May; 36(6):1711-1721. PubMed ID: 33889959
[TBL] [Abstract][Full Text] [Related]
15. Disruption of Zebrafish Follicle-Stimulating Hormone Receptor (fshr) But Not Luteinizing Hormone Receptor (lhcgr) Gene by TALEN Leads to Failed Follicle Activation in Females Followed by Sexual Reversal to Males.
Zhang Z; Lau SW; Zhang L; Ge W
Endocrinology; 2015 Oct; 156(10):3747-62. PubMed ID: 25993524
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.
Alviggi C; Conforti A; Santi D; Esteves SC; Andersen CY; Humaidan P; Chiodini P; De Placido G; Simoni M
Hum Reprod Update; 2018 Sep; 24(5):599-614. PubMed ID: 29924306
[TBL] [Abstract][Full Text] [Related]
17. Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus.
Conforti A; Tüttelmann F; Alviggi C; Behre HM; Fischer R; Hu L; Polyzos NP; Chuderland D; Rama Raju GA; D'Hooghe T; Simoni M; Sunkara SK; Longobardi S
Front Endocrinol (Lausanne); 2021; 12():797365. PubMed ID: 35178027
[TBL] [Abstract][Full Text] [Related]
18. Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response.
Lledo B; Guerrero J; Turienzo A; Ortiz JA; Morales R; Ten J; Llacer J; Bernabeu R
Pharmacogenet Genomics; 2013 May; 23(5):262-8. PubMed ID: 23470615
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variants of Gonadotropins and Their Receptors Could Influence Controlled Ovarian Stimulation: IVF Data from a Prospective Multicenter Study.
Alviggi C; Longobardi S; Papaleo E; Santi D; Alfano S; Vanni VS; Campitiello MR; De Rosa P; Strina I; Huhtaniemi I; Pursiheimo JP; D'Hooghe T; Humaidan P; Conforti A
Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372449
[TBL] [Abstract][Full Text] [Related]
20. Frequency of the T307A, N680S, and -29G>A single-nucleotide polymorphisms in the follicle-stimulating hormone receptor in Mexican subjects of Hispanic ancestry.
García-Jiménez G; Zariñán T; Rodríguez-Valentín R; Mejía-Domínguez NR; Gutiérrez-Sagal R; Hernández-Montes G; Tovar A; Arechavaleta-Velasco F; Canto P; Granados J; Moreno-Macias H; Tusié-Luna T; Pellicer A; Ulloa-Aguirre A
Reprod Biol Endocrinol; 2018 Oct; 16(1):100. PubMed ID: 30340493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
